{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T14:30:34Z","timestamp":1787927434876,"version":"build-2784847793"},"reference-count":33,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"American College of Veterinary Dermatology"},{"name":"Australian and New Zealand College of Veterinary Scientists Dermatology Chapter"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Increased antimicrobial resistance highlights the need for alternatives to antibiotics. Bacteriophages, which are benign viruses that kill bacteria, are promising. We studied the efficacy of topical bacteriophages for treating equine staphylococcal superficial pyodermas. Eight Staphylococcus aureus isolates were tested against a bacteriophage bank, and a cocktail consisting of two bacteriophages was prepared. Twenty horses with clinical and cytological evidence of superficial pyoderma and confirmed S. aureus infection based on swabbed culture were enrolled in the study. Each horse received both the bacteriophage cocktail and the placebo at two different infection sites, once daily for four weeks. Clinical lesions and cytology were evaluated weekly by an investigator who was unaware of the treatment sites. All infection sites were swabbed and cultured at the end of the study. A linear mixed model showed no significant differences between the placebo and treatment sites in terms of clinical signs, cytological scores of inflammation, and bacterial counts at the end of the study. It is possible that the bacteriophage cocktail killed S. aureus, but cytology scores did not change as new populations of cocci took over. The study limitations included a small sample size and inconsistent control of the underlying causes of pyodermas.<\/jats:p>","DOI":"10.3390\/pathogens12060828","type":"journal-article","created":{"date-parts":[[2023,6,15]],"date-time":"2023-06-15T02:28:56Z","timestamp":1686796136000},"page":"828","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Topical Bacteriophage Therapy for Staphylococcal Superficial Pyoderma in Horses: A Double-Blind, Placebo-Controlled Pilot Study"],"prefix":"10.3390","volume":"12","author":[{"given":"Kalie","family":"Marshall","sequence":"first","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosanna","family":"Marsella","sequence":"additional","affiliation":[{"name":"Department of Small Animal Clinical Sciences, College of Veterinary Medicine, University of Florida, 2015 SW 16th Avenue, Gainesville, FL 32610, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,6,14]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"162","DOI":"10.4292\/wjgpt.v8.i3.162","article-title":"Phage therapy: An alternative to antibiotics in the age of multi-drug resistance","volume":"8","author":"Lin","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Ther."},{"key":"ref_2","unstructured":"Kasman, L.M., and Porter, L.D. (2022). StatPearls, StatPearls Publishing."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2217\/fmb.12.97","article-title":"Bacteriophage endolysins as novel antimicrobials","volume":"7","author":"Schmelcher","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Lynch, S.A., and Helbig, K.J. (2021). The Complex Diseases of Staphylococcus pseudintermedius in Canines: Where to Next?. Vet. Sci., 8.","DOI":"10.3390\/vetsci8010011"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3389\/fmed.2020.00234","article-title":"Lytic Activity of Polyvalent Staphylococcal Bacteriophage PhiSA012 and Its Endolysin Lys-PhiSA012 Against Antibiotic-Resistant Staphylococcal Clinical Isolates From Canine Skin Infection Sites","volume":"7","author":"Nakamura","year":"2020","journal-title":"Front. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.resmic.2008.05.001","article-title":"Exploring the prokaryotic virosphere","volume":"159","author":"Comeau","year":"2008","journal-title":"Res. Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/bies.201400152","article-title":"A century of phage research: Bacteriophages and the shaping of modern biology","volume":"37","author":"Keen","year":"2015","journal-title":"Bioessays"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"3767","DOI":"10.1128\/AEM.65.9.3767-3773.1999","article-title":"Biocontrol of Escherichia coli O157 with O157-specific bacteriophages","volume":"65","author":"Kudva","year":"1999","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s00253-003-1438-9","article-title":"Toward rational control of Escherichia coli O157:H7 by a phage cocktail","volume":"64","author":"Tanji","year":"2004","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/fmb.13.47","article-title":"Phage cocktails and the future of phage therapy","volume":"8","author":"Chan","year":"2013","journal-title":"Future Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/ciy947","article-title":"A Systematic and Critical Review of Bacteriophage Therapy Against Multidrug-resistant ESKAPE Organisms in Humans","volume":"69","author":"Harb","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2174\/0929867322666150209152851","article-title":"Bacteriophages and phage-derived proteins\u2014Application approaches","volume":"22","author":"Maciejewska","year":"2015","journal-title":"Curr. Med. Chem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.3389\/fmicb.2017.02660","article-title":"Applications for Bacteriophage Therapy during Pregnancy and the Perinatal Period","volume":"8","author":"Furfaro","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1073\/pnas.1520056113","article-title":"Temperate phages both mediate and drive adaptive evolution in pathogen biofilms","volume":"113","author":"Davies","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Chaudhry, W.N., Concepci\u00f3n-Acevedo, J., Park, T., Andleeb, S., Bull, J.J., and Levin, B.R. (2017). Synergy and Order Effects of Antibiotics and Phages in Killing Pseudomonas aeruginosa Biofilms. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0168615"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.diagmicrobio.2014.08.018","article-title":"Treating periprosthetic joint infections as biofilms: Key diagnosis and management strategies","volume":"81","author":"Tzeng","year":"2015","journal-title":"Diagn. Microbiol. Infect. Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3390\/v4040471","article-title":"Bacteriophages with the ability to degrade uropathogenic Escherichia coli biofilms","volume":"4","author":"Chibeu","year":"2012","journal-title":"Viruses"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0041-1345(03)00525-6","article-title":"Bacteriophages as an efficient therapy for antibiotic-resistant septicemia in man","volume":"35","author":"Mulczyk","year":"2003","journal-title":"Transplant. Proc."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ka\u017amierczak, N., Grygorcewicz, B., Roszak, M., Bochentyn, B., and Piechowicz, L. (2022). Comparative Assessment of Bacteriophage and Antibiotic Activity against Multidrug-Resistant Staphylococcus aureus Biofilms. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms23031274"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"226","DOI":"10.4161\/viru.25991","article-title":"A historical overview of bacteriophage therapy as an alternative to antibiotics for the treatment of bacterial pathogens","volume":"5","author":"Wittebole","year":"2014","journal-title":"Virulence"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.vetmic.2010.05.014","article-title":"Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: A before\/after clinical trial","volume":"146","author":"Hawkins","year":"2010","journal-title":"Vet. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"5332","DOI":"10.1128\/AEM.01166-16","article-title":"Phage Therapy Is Effective in a Mouse Model of Bacterial Equine Keratitis","volume":"82","author":"Furusawa","year":"2016","journal-title":"Appl. Environ. Microbiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1089\/phage.2022.0004","article-title":"Discovery of the First Lytic Staphylococcus pseudintermedius\/Staphylococcus aureus Polyvalent Bacteriophages","volume":"3","author":"Clark","year":"2022","journal-title":"Phage"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/S0140-6736(05)74059-9","article-title":"Phage therapy\u2014Advantages over antibiotics?","volume":"356","author":"Pirisi","year":"2000","journal-title":"Lancet"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1136\/vr.152.5.138","article-title":"Bacteriological and mycological findings, and in vitro antibiotic sensitivity of pathogenic staphylococci in equine skin infections","volume":"152","author":"Chiers","year":"2003","journal-title":"Vet. Rec."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mib.2011.07.028","article-title":"The next generation of bacteriophage therapy","volume":"14","author":"Lu","year":"2011","journal-title":"Curr. Opin. Microbiol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3389\/fmed.2017.00094","article-title":"Phage Therapy in a 16-Year-Old Boy with Netherton Syndrome","volume":"4","author":"Zhvania","year":"2017","journal-title":"Front. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12250-014-3557-0","article-title":"Experience of the Eliava Institute in bacteriophage therapy","volume":"30","author":"Kutateladze","year":"2015","journal-title":"Virol. Sin."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/jalm\/jfac051","article-title":"Preliminary Reproducibility Evaluation of a Phage Susceptibility Testing Method Using a Collection of Escherichia coli and Staphylococcus aureus Phages","volume":"7","author":"Cunningham","year":"2022","journal-title":"J. Appl. Lab. Med."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Oliveira, H., Sampaio, M., Melo, L.D.R., Dias, O., Pope, W.H., Hatfull, G.F., and Azeredo, J. (2019). Staphylococci phages display vast genomic diversity and evolutionary relationships. BMC Genom., 20.","DOI":"10.1186\/s12864-019-5647-8"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2217\/fmb.16.11","article-title":"Intranasal treatment with bacteriophage rescues mice from Acinetobacter baumannii-mediated pneumonia","volume":"11","author":"Wang","year":"2016","journal-title":"Future Microbiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"752930","DOI":"10.1155\/2015\/752930","article-title":"Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice","volume":"2015","author":"Cao","year":"2015","journal-title":"BioMed Res. Int."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Duplessis, C.A., and Biswas, B. (2020). A Review of Topical Phage Therapy for Chronically Infected Wounds and Preparations for a Randomized Adaptive Clinical Trial Evaluating Topical Phage Therapy in Chronically Infected Diabetic Foot Ulcers. Antibiotics, 9.","DOI":"10.3390\/antibiotics9070377"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/6\/828\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:54:42Z","timestamp":1760126082000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/6\/828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,14]]},"references-count":33,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6]]}},"alternative-id":["pathogens12060828"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12060828","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,14]]}}}